GAST and gastrin-producing neuroendocrine tumor: Markers of gastrinoma aggressiveness can be recognized in elevated fasting gastrin levels, poor tumoral differentiation, high mitotic number, Ki 67 positivity, and expression of progesterone receptors [88].